Who is Bora?
Operating globally, we are focused on developing, manufacturing, and selling branded, generic and over the counter (OTC) healthcare products for patients in Taiwan and around the world.
Bora Pharmaceuticals and our group of companies is a publicly traded company on the Taipei Exchange (6472). We are Taiwan’s largest CDMO with a 50-year history in the Pharmaceutical Industry. We supply drugs to over 100 countries in the world, including the US/Canada, Japan, EU, Asia, Middle East, and South and Central America. We provide outsourced CDMO, and CMO services for global pharmaceutical companies around the world.
We achieve our market leadership through dedication to the best in class:
Bora Pharmaceuticals’ origins began from Hoan Pharmaceuticals. Started in 1972 by Mr. John W. Sheng, it focused on in-licensing and distribution of Pharmaceuticals in Taiwan. Bora Pharmaceuticals was established in 2007 as a separate entity focused on innovative drug development and high-quality CDMO production for International markets.
Partner With Us
The Bora Pharmaceuticals group offers a comprehensive portfolio of expertise. We can guide you through the complex challenges of the Taiwan healthcare market.
We partner with innovative and leading pharmaceutical companies to enable the development, manufacture and packaging of small molecule drug products and large molecule drug substance.